Other Information
−Removed: Not applicable .
−Removed: Rule 13a-14(a)/ 15d-14(a) Certification of Principal Executive Officer*
+Added: During the fiscal quarter ended March 31, 2026, none of the Company’s directors or officers adopted , modified , or terminated a Rule 10b5-1 trading arrangement, or a non-Rule 10b5-1 trading arrangement, in each case as defined in Item 408 of Regulation S-K.
+Added: Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer*
Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*
−Removed: Section 1350 Certification of Principal Executive Officer**
+Added: Section 1350 Certification of Chief Executive Officer**
Section 1350 Certification of Chief Financial Officer**
12 unchanged sentences
INmune Bio Inc.
−Removed: October 30, 2025
/s/ David Moss
1 unchanged sentence
(Principal Executive Officer)
−Removed: October 30, 2025
/s/ Cory Ellspermann
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.